EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race

Benjamin N Schmeusser iD, Dattatraya H Patil iD, Edouard H Nicaise iD, Manuel Armas-Phan, Reza Nabavizadeh, Vikram M Narayan iD, Shreyas S Joshi iD, Kenneth Ogan, Adeboye O Osunkoya, Mehmet A Bilen iD, Viraj A Master

Cancer · 2024

DOI: 10.1002/cncr.35037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Benjamin N Schmeusser und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: John Robinson Family Foundation, Cox Immunology Fund, Christopher Churchill Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The 2018 Leibovich prognostic model for nonmetastatic renal cell carcinoma (RCC) combines clinical, surgical, and pathologic factors to predict progression‐free survival (PFS) and cancer‐specific survival (CSS) for patients with clear cell (ccRCC), papillary (pRCC), and chromophobe (chRCC) histology. Despite high accuracy,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPrognosisProgression-Free SurvivalRetrospective Studies

Stichwörter der Autor:innen

Black racecancer-specific mortalityhistologykidney cancerprogression-free survival

Autor:innen und Institutionen

  • Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
  • Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Benjamin N Schmeusser, Dattatraya H Patil, Edouard H Nicaise, Vikram M Narayan, Shreyas S Joshi, Mehmet A Bilen

Förderung

  • John Robinson Family Foundation
  • Cox Immunology Fund
  • Christopher Churchill Foundation

Zitieren

APA

Schmeusser, B. N., Patil, D. H., Nicaise, E. H., Armas-Phan, M., Nabavizadeh, R., Narayan, V. M., Joshi, S. S., Ogan, K., Osunkoya, A. O., Bilen, M. A., & Master, V. A. (2024). 2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Cancer. https://doi.org/10.1002/cncr.35037

Vancouver

Schmeusser BN, Patil DH, Nicaise EH, Armas-Phan M, Nabavizadeh R, Narayan VM, et al. 2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Cancer. 2024. doi:10.1002/cncr.35037

BibTeX
@article{Schmeusser2024,
  author = {Schmeusser, Benjamin N and Patil, Dattatraya H and Nicaise, Edouard H and Armas-Phan, Manuel and Nabavizadeh, Reza and Narayan, Vikram M and Joshi, Shreyas S and Ogan, Kenneth and Osunkoya, Adeboye O and Bilen, Mehmet A and Master, Viraj A},
  title = {2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35037}
}
Kostenlos starten →